Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M18,274Revenue $M4,561Net Margin (%)11.4Z-Score3.8
Enterprise Value $M21,373EPS $1.0Operating Margin %18.7F-Score7
P/E(ttm))34.8Cash Flow Per Share $0Pre-tax Margin (%)16.0Higher ROA y-yY
Price/Book14.710-y EBITDA Growth Rate %0Quick Ratio1.9Cash flow > EarningsY
Price/Sales4.05-y EBITDA Growth Rate %0Current Ratio3.1Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %20.5ROA % (ttm)8.2Higher Current Ratio y-yY
Dividend Yield %0.8Insider Buy (3m)0ROE % (ttm)53.6Less Shares Outstanding y-yN
Payout Ratio %26.0Shares Outstanding M501ROI % (ttm)8.4Gross Margin Increase y-yY

Gurus Latest Trades with ZTS

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ZTSJoel Greenblatt 2014-06-30 Reduce$28.4 - $32.89
($30.65)
$ 37.0121%Reduce -22.04%33,034
ZTSJean-Marie Eveillard 2014-06-30 Reduce-0.12%$28.4 - $32.89
($30.65)
$ 37.0121%Reduce -42.15%2,177,060
ZTSGeorge Soros 2014-03-31 Add0.49%$29.01 - $32.69
($30.64)
$ 37.0121%Add 68.52%4,205,043
ZTSVanguard Health Care Fund 2014-03-31 Add0.16%$29.01 - $32.69
($30.63)
$ 37.0121%Add 23.89%10,421,717
ZTSJoel Greenblatt 2014-03-31 Buy 0.02%$29.01 - $32.69
($30.64)
$ 37.0121%New holding, 42374 sh.42,374
ZTSLee Ainslie 2014-03-31 Sold Out -3.2%$29.01 - $32.69
($30.64)
$ 37.0121%Sold Out0
ZTSJean-Marie Eveillard 2014-03-31 Reduce-0.26%$29.01 - $32.69
($30.64)
$ 37.0121%Reduce -43.39%3,763,386
ZTSLee Ainslie 2013-12-31 Add3.05%$31.04 - $33.22
($31.88)
$ 37.0116%Add 2021.15%7,635,025
ZTSGeorge Soros 2013-12-31 Add0.24%$31.04 - $33.22
($31.88)
$ 37.0116%Add 54.13%2,495,329
ZTSJean-Marie Eveillard 2013-09-30 Add0.5%$29.15 - $32.72
($30.63)
$ 37.0121%Add 1447.21%5,842,948
ZTSLee Ainslie 2013-09-30 Buy 0.15%$29.15 - $32.72
($30.63)
$ 37.0121%New holding, 359948 sh.359,948
ZTSMario Gabelli 2013-09-30 Add0.04%$29.15 - $32.72
($30.63)
$ 37.0121%Add 350.26%244,760
ZTSRuane Cunniff 2013-09-30 Add0.03%$29.15 - $32.72
($30.63)
$ 37.0121%Add 767.96%173,973
ZTSJohn Keeley 2013-09-30 Add0.02%$29.15 - $32.72
($30.63)
$ 37.0121%Add 95.24%81,519
ZTSGeorge Soros 2013-09-30 Reduce-0.26%$29.15 - $32.72
($30.63)
$ 37.0121%Reduce -32.68%1,619,011
ZTSJoel Greenblatt 2013-09-30 Sold Out -0.04%$29.15 - $32.72
($30.63)
$ 37.0121%Sold Out0
ZTSVanguard Health Care Fund 2013-06-30 Add0.88%$30.19 - $34.26
($32.38)
$ 37.0114%Add 1167.44%8,412,017
ZTSGeorge Soros 2013-06-30 Add0.59%$30.19 - $34.26
($32.38)
$ 37.0114%Add 262.41%2,404,811
ZTSJoel Greenblatt 2013-06-30 Buy 0.04%$30.19 - $34.26
($32.38)
$ 37.0114%New holding, 30457 sh.30,457
ZTSJean-Marie Eveillard 2013-06-30 Add0.03%$30.19 - $34.26
($32.38)
$ 37.0114%Add 655.29%377,645
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ZTS is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ZTS George Soros 2014-06-304,386,6350.881.1+4.32%
ZTS Vanguard Health Care Fund 2014-06-3010,798,4172.160.92+3.61%
ZTS Ruane Cunniff 2014-06-30173,5620.030.03+0.01%
ZTS John Keeley 2014-06-3074,5040.010.04-5.82%
ZTS Mario Gabelli 2014-06-30242,9800.050.04-6.74%
ZTS Joel Greenblatt 2014-06-3033,0340.010.01-22.04%
ZTS Jean-Marie Eveillard 2014-06-302,177,0600.430.17-42.15%
Premium Most recent portfolio changes are included for Premium Members only!


ZTS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MCCALLISTER MICHAEL BDirector 2013-08-08Buy7,000$31.3517.86view
Knupp Catherine A.Executive Vice President 2013-02-06Buy1,000$2642.12view
Chen Heidi C.Executive Vice President 2013-02-06Buy2,500$2642.12view
Beaty Sandra J.Executive Vice President 2013-02-06Buy2,000$2642.12view
STEERE WILLIAM C JRDirector 2013-02-06Buy4,500$2642.12view
Norden GregoryDirector 2013-02-06Buy3,000$2642.12view
SCHULMAN AMY WDirector 2013-02-06Buy5,000$2642.12view
HILL CHARLES HDirector 2013-02-06Buy5,000$2642.12view
Giordano Douglas E.Director 2013-02-06Buy5,000$2642.12view
Germano Geno JDirector 2013-02-06Buy5,000$2642.12view

Press Releases about ZTS :

    Quarterly/Annual Reports about ZTS:

    News about ZTS:

    Articles On GuruFocus.com
    Guru Stocks at 52-Week Lows: HMC, NMR, SDRL, ZTS, BBBY Apr 21 2014 
    Morning Coffee: Widely Held Guru Stocks Near 52-Week Lows Apr 10 2014 
    Morning Coffee: Guru Stocks Near 52-Week Lows Apr 03 2014 
    Guru Stocks at 52-Week Lows: CEO, BCS, HMC, ED, ZTS Apr 01 2014 
    Morning Coffee: Widely Held Guru Stocks Near 52-Week Lows Mar 28 2014 
    Steven Cohen's Top Five Holdings Nov 19 2013 
    5-Year Lows: Exelon Corp, Grupo Financiero Santander Mexico SAB de CV, Zoetis Inc, Encana Corp Nov 10 2013 
    Stocks at 5-Year Lows: BSBT, ZTS, ECA Sep 03 2013 
    Consensus Stocks ‘A to Z’ - Second Quarter Action Aug 07 2013 
    Vanguard Health Care Fund Buys Vertex Pharmaceuticals, Zoetis Inc, , Sells Cerner Corporation, AbbVi Aug 02 2013 

    More From Other Websites
    Zoetis to Host Webcast and Conference Call on Third Quarter 2014 Financial Results Sep 30 2014
    Focusing Solely On Animal Health Sets Zoetis Apart Sep 26 2014
    Bayer Deal for Zoetis in Sight After Unit Sale: Real M&A Sep 18 2014
    Bayer hits record high on move to list plastics business Sep 18 2014
    Bayer to float plastics business and focus on life sciences Sep 18 2014
    Zoetis Ranked Among Top Ten Companies for Working Mothers Sep 16 2014
    ZOETIS INC. Files SEC form 8-K, Change in Directors or Principal Officers Sep 15 2014
    The Difference Between Europe and Us Sep 05 2014
    [$$] Zoetis Gets Conditional License for Swine Vaccine Sep 03 2014
    Zoetis granted conditional license by USDA for PEDv vaccine Sep 03 2014
    [video] Cramer's Mad Dash: Zoetis Sep 03 2014
    [video] Cramer's stocks to watch: Zoetis' PEDv vaccine Sep 03 2014
    Zoetis Granted Conditional License for Porcine Epidemic Diarrhea Vaccine* Sep 03 2014
    ZOETIS INC. Financials Aug 20 2014
    Zoetis to Participate in Bank of America Merrill Lynch Global Healthcare Conference Aug 20 2014
    ZOETIS INC. Files SEC form 8-K, Change in Directors or Principal Officers Aug 14 2014
    Zoetis Announces Appointment of Paul Herendeen as Executive Vice President and Chief Financial... Aug 14 2014
    Zoetis to Participate in Morgan Stanley Global Healthcare Conference Aug 13 2014
    ZOETIS INC. Files SEC form 10-Q, Quarterly Report Aug 12 2014
    Cannabis Therapy Expands into Animal Health Marketplace Aug 06 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK